AICA riboside prodrugs
US5082829A · kind A · utility
12Cited by
3References
26Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 24, 1989 |
| Grant date | Jan 21, 1992 |
| Priority date | — |
| Expiry date | Jan 24, 2009 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07H19/052
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Prodrugs of AICA riboside are provided which increase the bioavailability of AICA riboside and thereby increase extracellular concentrations of the prophylactic and affirmative treatment of various pathologic conditions, including ischemia. Also provided are methods of using AICA riboside prodrugs in treating such conditions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.